Fig. 10From: Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based studyFerric reducing antioxidant power (FRAP) of most active compounds with respect to reference l-ascorbic acidBack to article page